After a series of setbacks, Pfizer is entering Phase 3 trials with a new long-acting injectable, MET-097i
2 capsules per serving 60 servings 120 capsules 60-day supply
A method of reversing, ameliroating or slowing progression of at least one symptom of Parkinson's disease in a patient in need thereof, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to reverse, ameliorate or slow progression of said at least one symptom of Parkinson's disease, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 wherein Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Quick Answer: Wegovy can cause a bad taste in the mouth (dysgeusia) in some patients, though this is not listed as a common side effect in UK regulatory documentation
Participants were well matched across groups in terms of mean age, sex, education level and post-mortem interval (Fig
